Evicenter
P&T meetings

Ulixacaltamide

Essential tremor

Regulatory submission
NDA submitted by February 2026
Launch
Not announced
Last updated
78 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Essential tremor

Humanistic burden and health-related quality of life

2 evidence topics · 3 sources

Work and activity impairment

“Work impairment is significantly correlated with tremor severity.” (opens the source at this quote in a new tab)

Disease-specific quality-of-life instrument validation

“Preliminary validity data are encouraging.” (opens the source at this quote in a new tab)